Apellis Pharmaceuticals

• 10/23/2024

  3 Undervalued Stocks to Buy in a Pricey Market

• 10/23/2024

  Baron Health Care Fund: Q3 2024 Insights & Performance

• 10/23/2024

  Merck’s RSV Breakthrough: Experimental Treatment Shields Infants

• 10/22/2024

  Nasdaq Futures Soar: TSMC Outlook Calms AI Fears

• 10/22/2024

  Tectonic Therapeutic Stock Soars 100% on Breakthrough Pulmonary Hypertension Treatment

• 10/19/2024

  UnitedHealth Q3 Earnings: Why the Sell-Off Isn’t a Buying Opportunity

• 10/7/2024

  **Super Micro Makes Big Progress**

• 

  10/4/2024

  **US Dividend ETFs Surge After Fed Rate Cut**

• 

  10/4/2024

  **Emergent BioSolutions: A Turnaround Opportunity**

• 

  10/4/2024

  **Apellis: Balancing Rapid Growth with GA Market Risks (Rating Upgrade)**